Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Meningioma × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Neoplasms 8 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Hydroxyurea 3 Bevacizumab 3 pembrolizumab 2 Imatinib Mesylate 2 Everolimus 2 vatalanib 1 pasireotide 1 fludarabine phosphate 1 fludarabine 1 arginyllysine 1 antineoplaston AS 2-1 1 antineoplaston A10 1 aldesleukin 1 Whole Body Imaging 1 Verapamil 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Modafinil 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fentanyl 1 Erlotinib Hydrochloride 1 Donepezil 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡